Blood Parameter Analysis of Pediatric Patients Who Underwent Adenotonsillectomy Due to Upper Airway Obstruction

Abstract

Background: The most common cause of obstructive sleep apnea syndrome (OSAS) in the pediatric age group is adenotonsillar hypertrophy. In our study, we aimed to investigate inflammatory changes in blood parameters in patients who underwent adenotonsillectomy due to upper respiratory tract obst-ruction. Materials and Methods: 50 patients who were operated on due to adenotonsillar hypertrophy, who applied to the outpatient clinic with a complaint of witnessed apnea, were retrospectively examined. Complete blood count (CBC) parameters of the patients before surgery and at the 6th month postope-rative follow-up were evaluated. In our study, neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR), mean platelet volume (MPV), the ratio of WBC to MPV (WMR), red blood cell distribution width (RDW), platelet distribution width (PDW). The changes in ) values after surgery were examined. Results: The study was conducted with a total of 50 cases, 36% (n=18) of which were girls and 64% (n=32) were boys. The ages of the cases ranged between 5 and 13, and the average age was 9.28±2.53. In our study, the decrease in WMR, MPV, and NLR measurements after surgery was found to be statisti-cally significant (p<0.01). Additionally, the decrease in PDW measurements was found to be statistically significant (p<0.05). RDW and PLR measurement changes in our study do not show a statistically signifi-cant difference (p>0.05). Conclusions: This study showed that prothrombotic values improved after adenotonsillectomy in pa-tients with upper airway obstruction due to adenotonsillar hypertrophy. Our results demonstrate the effectiveness and necessity of surgery in patients with upper airway obstruction.

Keywords

• Adenotonsillectomy
• Obstructive sleep apnea syndrome
• Pediatric patient
• Blood parameters

Üst Hava Yolu Obstrüksiyonu Nedeniyle Adenotonsillektomi Yapılan Pediatrik Hastaların Kan Parametrelerinin Analizi

Abstract

Amaç: Pediatrik yaş grubunda obstrüktif uyku apne sendromu (OSAS)’ nun en sık görülen nedeni adenotonsiller hipertrofidir. Çalışmamızda üst solunum yolu obstrüksiyonu nedeniyle adenotonsillektomi yapılan hastalarda kan parametrelerindeki inflamatuar değişiklikleri göstermeyi amaçladık. Materyal ve metod: Tanıklı apne nedeniyle polikliniğe başvuran adenotonsiller hipertrofi nedeniyle opere edilen 50 hasta retrospektif olarak incelendi. Hastaların ameliyat öncesi ve ameliyat sonrası 6. Ay kontrolünde bakılan Tam kan sayımı (CBC) parametreleri değerlendirildi. Çalışmamızda Nötrofil lenfosit oranı (NLR), platellet lenfosit oranı (PLR), ortalama platellet hacmi (MPV), platellet sayısı ve WBC’ nin MPV'ye oranı (WMR), kırmızı kan hücresi dağılım genişliği (RDW), platelet dağılım genişliği (PDW) değerlerinin ameliyat sonrasındaki değişimi incelendi. Bulgular: Çalışma %36’sı (n=18) kız, %64’ü (n=32) erkek olmak üzere toplam 50 olgu ile yapılmıştır. Olguların yaşları 5 ile 13 arasında değişmekte olup, ortalama yaş 9,28±2,53’tür. Çalışmamızda ameliyat sonrası WMR, MPV, NLR ölçümlerindeki düşüş istatistiksel olarak anlamlı saptanmıştır (p<0,01). Ayrıca PDW ölçümlerinde de düşüş istatistiksel olarak anlamlı saptanmıştır (p<0,05). Çalışmamızdaki RDW ve PLR ölçümü değişimleri istatistiksel olarak anlamlı farklılık göstermemektedir (p>0,05). Sonuç: Bu çalışmamız bize adenotonsiller hipertrofi nedeniyle üst solunum yolu obstrüksiyonu olan hastaların ameliyat sonrası protrombotik değerlerinde düzelme olduğunu göstermektedir. Sonuçlarımız üst solunum yolu obstrüksiyonu olan hastalarda cerrahinin etkililiğini ve gerekliliğini göstermektedir.

Keywords

• Adenotonsillektomi
• Obstüriktif uyku apne Sendromu
• Çocuk hasta
• Kan parametreleri

References

1. 1. Blum RH, McGowan Jr FX. Chronic upper airway obstruction and cardiac dysfunction: anatomy, pathophysiology and anes-thetic implications. Pediatric Anesthesia. 2004;14(1):75-83.
2. 2. Gislason T, Benediktsdottir B. Snoring, apneic episodes, and nocturnal hypoxemia among children 6 months to 6 years old: an epidemiologic study of lower limit of prevalence. Chest. 1995;107(4):963-6.
3. 3. Tatlipinar A, Duman D, Uslu C, Egeli E. The effects of obstruc-tive sleep apnea syndrome due to adenotonsillar hypertrophy on the cardiovascular system in children. The Turkish journal of pediatrics. 2011;53(4):359-63.
4. 4. Li H-Y, Lee L-A. Sleep-disordered breathing in children. Chang Gung Med J. 2009;32(3):247-57.
5. 5. Badran M, Ayas N, Laher I. Cardiovascular complications of sleep apnea: role of oxidative stress. Oxidative medicine and cellular longevity. 2014;2014.
6. 6. Garvey J, Taylor C, McNicholas W. Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation. European Respiratory Journal. 2009;33(5):1195-205.
7. 7. Tamisier R, Pépin J, Rémy J, Baguet J, Taylor J, Weiss J et al. 14 nights of intermittent hypoxia elevate daytime blood pres-sure and sympathetic activity in healthy humans. European respiratory journal. 2011;37(1):119-28.
8. 8. Kang K-T, Weng W-C, Yeh T-H, Lee P-L, Hsu W-C. Validation of the Chinese version OSA-18 quality of life questionnaire in Taiwanese children with obstructive sleep apnea. Journal of the Formosan Medical Association. 2014;113(7):454-62.

9. 9. Schechter M. Diagnosis and management of childhood ob-structive sleep apnea syndrome. Pediatrics. 2002;109:1-20.
10. 10. Kum RO, Ozcan M, Baklaci D, Kum NY, Yilmaz YF, Unal A et al. Investigation of neutrophil-to-lymphocyte ratio and mean platelet volume in sudden hearing loss. Brazilian journal of otorhinolaryngology. 2015;81:636-41.
11. 11. Kum RO, Yurtsever Kum N, Ozcan M, Yilmaz YF, Gungor V, Unal A et al. Elevated neutrophil-to-lymphocyte ratio in Bell’s palsy and its correlation with facial nerve enhancement on MRI. Otolaryngology--Head and Neck Surgery. 2015;152(1):130-5.
12. 12. Nena E, Papanas N, Steiropoulos P, Zikidou P, Zarogoulidis P, Pita E et al. Mean platelet volume and platelet distribution width in non-diabetic subjects with obstructive sleep apnoea syndrome: new indices of severity? Platelets. 2012;23(6):447-54.
13. 13. Varol E, Ozturk O, Gonca T, Has M, Ozaydin M, Erdogan D et al. Mean platelet volume is increased in patients with severe obstructive sleep apnea. Scandinavian journal of clinical and laboratory investigation. 2010;70(7):497-502.
14. 14. Yilmaz YF, Kum RO, Ozcan M, Gungor V, Unal A. Drug‐induced sleep endoscopy versus M üller maneuver in patients with retropalatal obstruction. The Laryngoscope. 2015;125(9):2220-5.
15. 15. Koseoglu HI, Altunkas F, Kanbay A, Doruk S, Etikan I, Demir O. Platelet–lymphocyte ratio is an independent predictor for cardiovascular disease in obstructive sleep apnea syndrome. Journal of thrombosis and thrombolysis. 2015;39:179-85.
16. 16. Kum RO, Kundi FCS, Özcan M, Yılmaz YF, Kum NY, Ünal A. White blood cell count to mean platelet volume ratio: a novel marker for obstructive sleep apnea. KBB-Forum; 2017.
17. 17. Chan J, Edman JC, Koltai PJ. Obstructive sleep apnea in chil-dren. American family physician. 2004;69(5):1147-55.
18. 18. Yılmaz MD, Onrat E, Altuntaş A, Kaya D, Kahveci OK, Özel O, et al. The effects of tonsillectomy and adenoidectomy on pulmonary arterial pressure in children. American journal of otolaryngology. 2005;26(1):18- 21.
19. 19. Kapsoritakis AN, Koukourakis MI, Sfiridaki A, Potamianos SP, Kosmadaki MG, Koutroubakis IE, et al. Mean platelet volume: a useful marker of inflammatory bowel disease activity. Offi-cial journal of the American College of Gastroenterology| ACG. 2001;96(3):776-81.
20. 20. Kisacik B, Tufan A, Kalyoncu U, Karadag O, Akdogan A, Ozturk MA, et al. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint bone spine. 2008;75(3):291-4.
21. 21. Sagit M, Korkmaz F, Kavugudurmaz M, Somdas MA. Impact of septoplasty on mean platelet volume levels in patients with marked nasal septal deviation. Journal of Craniofacial Surgery. 2012;23(4):974-6.
22. 22. Varol E, Ozturk O, Yucel H, Gonca T, Has M, Dogan A et al The effects of continuous positive airway pressure therapy on mean platelet volume in patients with obstructive sleep ap-nea. Platelets. 2011;22(7):552-6.
23. 23. Kucur C, Kulekci S, Zorlu A, Savran B, Oghan F, Yildirim N. Mean platelet volume levels in children with adenoid hyper-trophy. Journal of Craniofacial Surgery. 2014;25(1):e29-e31.
24. 24. Onder S, Caypinar B, Sahin-Yilmaz A, Toros SZ, Oysu C. Rela-tion of mean platelet volume with obstructive adenoid hyper-trophy in children. International journal of pediatric otorhino-laryngology. 2014;78(9):1449-51.
25. 25. Zorlu D, Özyurt S, Bircan A, Ertürk A. Do complete blood count parameters predict diagnosis and disease severity in obstruc-tive sleep apnea syndrome? 2021.
26. 26. Zota IM, Adam CA, Marcu DTM, Stătescu C, Sascău R, Anghel L, et al. CPAP Influence on Readily Available Inflammatory Markers in OSA—A Pilot Study. International Journal of Mo-lecular Sciences. 2022;23(20):12431.
27. 27. Friščić T, Perčić M, Vidović D, Štajduhar A, Galić E. Impact of CPAP therapy on new inflammation biomarkers. Journal of clinical medicine. 2022;11(20):6113.
28. 28. Wu J, Yan L, Chai K. Systemic immune‐inflammation index is associated with disease activity in patients with ankylosing spondylitis. Journal of clinical laboratory analysis. 2021;35(9):e23964.
29. 29. Uslu AU, Küçük A, Şahin A, Ugan Y, Yılmaz R, Güngör T, et al. Two new inflammatory markers associated with Disease Ac-tivity Score‐28 in patients with rheumatoid arthritis: neutro-phil‐lymphocyte ratio and platelet‐lymphocyte ratio. Interna-tional journal of rheumatic diseases. 2015;18(7):731-5.
30. 30. Lisman T. Platelet–neutrophil interactions as drivers of in-flammatory and thrombotic disease. Cell and tissue research. 2018;371(3):567-76.
31. 31. Balta S, Demırkol S, Kucuk U, editors. The platelet lympho-cyte ratio may be useful inflammatory indicator in clinical practice. Hemodialysis International International Symposi-um on Home Hemodialysis; 2013.
32. 32. Gürpınar B, Özdemir C, Tutar B. Comparison of neutrophil to lymphocyte ratio in obstructive sleep apnea syndrome pheno-types. Eur Arch Med Res. 2020;36:136-40.
33. 33. Wu M, Zhou L, Zhu D, Lai T, Chen Z, Shen H. Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis. Jour-nal of Thoracic Disease. 2018;10(12):6509.
34. 34. Koseoglu S, Ozcan KM, Ikinciogullari A, Cetin MA, Yildirim E, Dere H. Relationship Between Neutrophil to Lymphocyte Ra-tio, Platelet to Lymphocyte Ratio and Obstructive Sleep Ap-nea Syndrome. Advances in Clinical and Experimental Medi-cine: Official Organ Wroclaw Medical University. 2015;24(4):623-7.
35. 35. Yenigun A, Karamanli H. Investigation of the relationship between neutrophil-to-lymphocyte ratio and obstructive sleep apnoea syndrome. The Journal of Laryngology & Otolo-gy. 2015;129(9):887-92.
36. 36. Aksakal C, Şahin M, Gürpınar AB. The effect of adult tonsil-lectomy in chronic tonsillits on neutrophil/lymphocyte ratio (NLR), platelet/lymphocyte ratio (PLR) and mean platelet volume (MPV). Ann Clin Anal Med. 2019;10:549-52.
37. 37. Bozlu G, Taskinlar H, Unal S, Alakaya M, Nayci A, Kuyucu N. Diagnostic value of red blood cell distribution width in pediat-ric acute appendicitis. Pediatrics International. 2016;58(3):202-5.
38. 38. Ozsu S, Abul Y, Gulsoy A, Bulbul Y, Yaman S, Ozlu T. Red cell distribution width in patients with obstructive sleep apnea syndrome. Lung. 2012;190:319-26.
39. 39. Sökücü SN, Karasulu L, Dalar L, Seyhan EC, Altın S. Can red blood cell distribution width predict severity of obstructive sleep apnea syndrome? Journal of Clinical Sleep Medicine. 2012;8(5):521-5.
40. 40. Kurt OK, Yildiz N. The importance of laboratory parameters in patients with obstructive sleep apnea syndrome. Blood Coag-ulation & Fibrinolysis. 2013;24(4):371-4.
41. 41. Vagdatli E, Gounari E, Lazaridou E, Katsibourlia E, Tsikopou-lou F, Labrianou I. Platelet distribution width: a simple, prac-tical and specific marker of activation of coagulation. Hip-pokratia. 2010;14(1):28.
42. 42. Boos CJ, Lip GY. Assessment of mean platelet volume in coronary artery disease—what does it mean? Thrombosis re-search. 2007;120(1):11-3.
43. 43. Ziegler MG, Nelesen R, Mills P, Ancoli-Israel S, Kennedy B, Dimsdale JE. Sleep apnea, norepinephrine-release rate, and daytime hypertension. Sleep. 1997;20(3):224-31.
44. 44. Ulu Ş, Bucak A, Köken R, Kuzu S, Ayçiçek A. Mean platelet volume as a potential marker for predicting hypoxia in chil-dren with adenotonsillar hypertrophy. Van Medical Journal. 2015;22(1):10-3.
45. 45. Di Lorenzo B, Scala C, Mangoni AA, Zoroddu S, Paliogiannis P, Pirina P, et al. A Systematic Review and Meta-Analysis of Mean Platelet Volume and Platelet Distribution Width in Pa-tients with Obstructive Sleep Apnoea Syndrome. Biomedi-cines. 2024;12(2):270.
46. 46. Song Y-J, Kwon JH, Kim JY, Kim BY, Cho KI. The platelet-to-lymphocyte ratio reflects the severity of obstructive sleep ap-nea syndrome and concurrent hypertension. Clinical Hyper-tension. 2015;22:1-8.
47. 47. Sökücü SN, Özdemir C, Dalar L, Karasulu L, Aydın Ş, Altın S. Complete blood count alterations after six months of contin-uous positive airway pressure treatment in patients with se-vere obstructive sleep apnea. Journal of Clinical Sleep Medi-cine. 2014;10(8):873-8.